The Department of Health on Friday warned against overpricing an investigational drug used on COVID-19 patients.
The department said a 100-milligram vial of remdesivir must only cost P1,500 to P8,200.
The department, in its warning, cited a joint administrative order with other government agencies that those “found to have committed any illegal act of price manipulation would be penalized administratively and criminally.”
The Philippines continues to battle a surge in COVID-19 infections that health authorities have attributed to new coronavirus variants, increased mobility and relaxed adherence to health protocols.
The department advised the public to send complaints on overpriced remdesivir to [email protected].
The department also said the use of the investigational drug required a compassionate use permit from the Food and Drug Administration.
The country’s supply of remdesivir and tocilizumab, another drug also used on COVID-19 cases, was replenished last month after a shortfall.